EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets

Hyun Joo Lee, Yunju Jo iD, Shibo Wei iD, Eun Hee Yu iD, Sul Lee iD, Dongryeol Ryu iD, Jong Kil Joo iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hyun Joo Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Pusan National University Hospital Biomedical Research Institu…. Hauptthemen laut MEDLINE: Biomarkers, Ovary, Membrane Proteins, Serine Endopeptidases. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pusan National University Hospital, Biomedical Research Institute Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronological age is an imprecise proxy for reproductive capacity, necessitating biomarkers that reflect the underlying pathophysiology of the ovary. Fibrotic remodeling of the ovarian stroma is a key hallmark of biological ovarian aging, yet it cannot be assessed by current clinical tools. This study aimed to identify and validate a novel serum biomarker for fibrotic ovarian aging by applying supervised machine learning (ML) to human ovarian transcriptomic data. Transcriptomic data from the Genotype-Tissue Expression (GTEx) database were analyzed using ML algorithms to identify candidate genes predictive of ovarian aging, and finally, fibroblast activation protein (FAP) and collectin-11 (COLEC11) were selected for clinical validation. In a cross-sectional study, serum levels of FAP and COLEC11, along with key hormonal indices, were measured in two nested patient cohorts, and their associations with ovarian reserve and clinical parameters were analyzed. Serum FAP levels did not correlate with age but showed a strong inverse correlation with anti-Müllerian hormone (AMH) (r = −0.61, p = 0.001), a finding accentuated in women with decreased ovarian reserve (DOR). While COLEC11 correlated with age, it failed to differentiate DOR status. FAP levels were independent of central hormonal regulation, consistent with preclinical fibrotic models. Circulating FAP reflects age-independent, fibrotic ovarian aging, offering stromal-specific information not captured by conventional hormonal markers. This study provides the first clinical validation of FAP as a biomarker for ovarian stromal aging, holding potential for improved reproductive risk assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersOvaryMembrane ProteinsSerine EndopeptidasesAgingTranscriptomeGelatinasesHumansFemaleAdultMiddle AgedFibrosisCross-Sectional StudiesOvarian ReserveAnti-Mullerian HormoneEndopeptidasesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

AMHbiomarkerfibroblast activation proteinovarian fibrosisovarian reservereproductive aging

Substanzen

BiomarkersMembrane ProteinsSerine EndopeptidasesGelatinasesAnti-Mullerian HormoneEndopeptidasesFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Pusan National University Hospital Biomedical Research Institute, Busan 49241, Republic of Korea.
  • Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.

ORCID-Profile: Yunju Jo, Shibo Wei, Eun Hee Yu, Sul Lee, Dongryeol Ryu, Jong Kil Joo

Förderung

  • Pusan National University Hospital
  • Biomedical Research Institute Grant

Zitieren

APA

Lee, H. J., Jo, Y., Wei, S., Yu, E. H., Lee, S., Ryu, D., & Joo, J. K. (2025). Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167807

Vancouver

Lee HJ, Jo Y, Wei S, Yu EH, Lee S, Ryu D, et al. Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167807

BibTeX
@article{Lee2025,
  author = {Lee, Hyun Joo and Jo, Yunju and Wei, Shibo and Yu, Eun Hee and Lee, Sul and Ryu, Dongryeol and Joo, Jong Kil},
  title = {Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167807}
}
Kostenlos starten →